ALGS
Price
$6.03
Change
-$0.42 (-6.51%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
39.78M
Intraday BUY SELL Signals
BEAM
Price
$21.66
Change
-$0.21 (-0.96%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
2.22B
110 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALGS vs BEAM

Header iconALGS vs BEAM Comparison
Open Charts ALGS vs BEAMBanner chart's image
Aligos Therapeutics
Price$6.03
Change-$0.42 (-6.51%)
Volume$358
Capitalization39.78M
Beam Therapeutics
Price$21.66
Change-$0.21 (-0.96%)
Volume$108.35K
Capitalization2.22B
ALGS vs BEAM Comparison Chart in %
View a ticker or compare two or three
VS
ALGS vs. BEAM commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and BEAM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ALGS: $6.45 vs. BEAM: $21.87)
Brand notoriety: ALGS and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 64% vs. BEAM: 71%
Market capitalization -- ALGS: $39.78M vs. BEAM: $2.22B
ALGS [@Biotechnology] is valued at $39.78M. BEAM’s [@Biotechnology] market capitalization is $2.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALGS and BEAM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 5 TA indicator(s) are bullish while BEAM’s TA Score has 4 bullish TA indicator(s).

  • ALGS’s TA Score: 5 bullish, 5 bearish.
  • BEAM’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, ALGS is a better buy in the short-term than BEAM.

Price Growth

ALGS (@Biotechnology) experienced а -11.94% price change this week, while BEAM (@Biotechnology) price change was -5.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.22B) has a higher market cap than ALGS($39.8M). BEAM YTD gains are higher at: -11.815 vs. ALGS (-83.798). ALGS has higher annual earnings (EBITDA): -75.81M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. ALGS (123M). ALGS has less debt than BEAM: ALGS (6.88M) vs BEAM (155M). BEAM has higher revenues than ALGS: BEAM (60.3M) vs ALGS (3.17M).
ALGSBEAMALGS / BEAM
Capitalization39.8M2.22B2%
EBITDA-75.81M-414.33M18%
Gain YTD-83.798-11.815709%
P/E RatioN/AN/A-
Revenue3.17M60.3M5%
Total Cash123M1.15B11%
Total Debt6.88M155M4%
TECHNICAL ANALYSIS
Technical Analysis
ALGSBEAM
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signal:
Gain/Loss:
BEAM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALVIX11.330.06
+0.53%
American Century Focused Lg Cap Val Inv
MCBVX29.940.10
+0.34%
MFS Mid Cap Value B
PECAX15.710.02
+0.13%
JPMorgan SMID Cap Equity A
JOMMX16.03-0.01
-0.06%
JOHCM Emerging Mkts Discovery Instl
WBVRX29.54-0.02
-0.07%
William Blair Small Cap Value R6

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with ARWR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
-3.37%
ARWR - ALGS
42%
Loosely correlated
-0.19%
BEAM - ALGS
41%
Loosely correlated
-2.71%
RXRX - ALGS
40%
Loosely correlated
-1.27%
XNCR - ALGS
40%
Loosely correlated
-3.23%
DSGN - ALGS
40%
Loosely correlated
-1.93%
More